Prevencio Receives FDA Breakthrough Device Designation for HART CADhs, Its Artificial Intelligence-driven Blood Test for Obstructive Coronary Artery Disease

Prevencio, a leader in AI-powered cardiovascular diagnostics, received new patents in the United Kingdom and Hong Kong for its HART CADhs® test, expanding its global portfolio to six patents. The test uses multiple protein biomarkers and machine learning to noninvasively diagnose obstructive coronary artery disease.